Back to search

Article

Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?

2020-01-11

Abstract excerpt

Abstract Chondrosarcomas are rare cancers of bone that arise from the malignant transformation of cells of chondrocytic lineage. They are known to be resistant to systemic cytotoxic chemotherapy and radiotherapy. The mainstay of management of localised disease is en bloc surgical resection with curative intent. Metastatic chondrosarcoma has a dismal prognosis, and to date, there are no proven effective systemic th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4faeea96-e829-58c7-9052-5ca6aa6a1a47
DOI
10.1007/s40610-020-00126-z
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?DOI 10.1007/s40610-020-00126-z
Select a neighboring publication to make it the new centre.